Using multiomics data from public databases such as TCGA, GTEx, and HPA, we systematically analyzed TIPE2 expression patterns, genetic and epigenetic alterations, and their associations with clinical outcomes and immune characteristics across 33 cancer types. This evidence concerns the gene TIPE2 and cancer.